Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Primary ciliary dyskinesia (PCD) is a genetic disease characterized by defects in motile cilia, which play an important role in several organ systems. Lung disease is a hallmark of PCD, given the essential role of cilia in airway surface defense. Diagnosis of PCD is complicated due to its reliance on complex tests that are not utilized by every clinic and also its phenotypic overlap with several other respiratory diseases. Nonetheless, PCD is increasingly being recognized as more common than once thought. The disease is genetically complex, with several genes reported to be associated with PCD. There is no cure for PCD, but gene therapy remains a promising therapeutic strategy. In this review, we provide an overview of the clinical symptoms, diagnosis, genetics, and current treatment regimens for PCD. We also describe PCD model systems and discuss the therapeutic potential of different gene therapeutics for targeting the intended cellular target, the ciliated cells of the airway.

Citation

Nicholas W Keiser, Erin Cant, Sneha Sitaraman, Amelia Shoemark, Maria P Limberis. Restoring Ciliary Function: Gene Therapeutics for Primary Ciliary Dyskinesia. Human gene therapy. 2023 Sep;34(17-18):821-835

Expand section icon Mesh Tags


PMID: 37624733

View Full Text